ASRT
NASDAQ
US
Assertio Holdings, Inc. - Common Stock
$19.21
▼ $-0.67
(-3.37%)
Vol 126K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$58.2M
ROE
-26.6%
Margin
-20.7%
D/E
37.02
Beta
0.58
52W
$1–$10
Wall Street Consensus
10 analysts · Apr 20262
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
90.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 60.0%
Next Report
May 11, 2026
EPS Estimate: $-2.00
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-2.00 | — | — |
| Dec 2025 | $-2.76 | $-1.86 | +$0.90 |
| Sep 2025 | $-1.30 | $1.80 | +$3.10 |
| Jun 2025 | $-1.16 | $-2.55 | $-1.39 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $32.2M | $26.5M | $29.2M | $49.5M | $13.5M |
| Net Income | — | -$10.5M | -$13.5M | -$16.4M | $11.4M | -$11.9M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -37.7% | -38.2% | -38.2% | -38.2% | -26.6% | -26.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -56.0% | -37.0% | -37.0% | -37.0% | -20.7% | -20.7% |
| Gross Margin | 63.5% | 67.9% | 67.9% | 67.9% | 68.2% | 68.2% |
| D/E Ratio | 41.85 | 41.85 | 41.85 | 41.85 | 37.02 | 37.02 |
| Current Ratio | 1.59 | 1.59 | 1.59 | 1.59 | 1.58 | 1.58 |
Key Ratios
ROA (TTM)
-9.8%
P/S (TTM)
0.42
P/B
0.7
EPS (TTM)
$-0.31
CF/Share
$-2.28
Rev Growth 3Y
+4.0%
52W High
$10.42
52W Low
$0.51
$0.51
52-Week Range
$10.42
Financial Health
Free Cash Flow
-$30.0M
Net Debt
$29.8M
Cash
$10.2M
Total Debt
$40.0M
As of Dec 31, 2025
How does ASRT compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
ASRT valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
0.4
▼
91%
below
peers
(5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
0.7
▼
68%
below
peers
(2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
ASRT profitability vs Pharmaceuticals peers
ROE
-26.6%
▲
51%
above
peers
(-54.3%)
vs Peers
vs Industry
Below avg
Net margin
-20.7%
▲
56%
above
peers
(-47.4%)
vs Peers
vs Industry
Below avg
Gross margin
68.2%
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
Weak
ROA
-9.8%
▲
74%
above
peers
(-37.4%)
vs Peers
vs Industry
Top tier
ASRT financial health vs Pharmaceuticals peers
D/E ratio
37.0
▲
2304%
above
peers
(1.5)
vs Peers
vs Industry
High debt
Current ratio
1.6
▼
53%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
0.6
▼
38%
below
peers
(0.9)
vs Peers
vs Industry
More volatile
ASRT fundamentals radar
ASRT
Peer median
Industry
ASRT profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ASRT vs peers: key metrics
Latest News
No related news yet